Epimers of moxalactam: in vitro comparison of activity and stability
- 1 July 1981
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 20 (1), 30-32
- https://doi.org/10.1128/aac.20.1.30
Abstract
Moxalactam exists in two epimeric forms, R and S. The in vitro activity of these two epimers was compared with that of material available for clinical and laboratory use (R + S moxalactam). Generally, R moxalactam was twice as active as the S form. The stability of R + S moxalactam was studied at 37, 20, 4 and -20 degrees C in buffer and serum. Only in serum at 37 degrees C was there any appreciable loss of activity (half-life, 8 h). The stability of R and S epimers was studied separately, and the composition of the resulting equilibrium was investigated. At 37 degrees C in serum, one-half of the excess of either R or S over the equilibrium mixture was converted into the equilibrium mixture in 1.5 h. The proportions of R to S in an equilibrium mixture in buffer were 50:50, but in serum they were 45:55. It is doubtful whether these differences in stability and activity will have any significant clinical importance.This publication has 6 references indexed in Scilit:
- The pharmacokinetics of LY127935, a broad spectrum oxa-β-lactamJournal of Antimicrobial Chemotherapy, 1980
- LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1979
- Antibacterial Activity of a New 1-Oxa Cephalosporin Compared with That of Other β-Lactam CompoundsAntimicrobial Agents and Chemotherapy, 1979
- Semisynthetic .beta.-lactam antibiotics. 2. Synthesis and properties of D- and L-.alpha.-sulfobenzylpenicillinsJournal of Medicinal Chemistry, 1972
- Novel Method for Detection of β-Lactamases by Using a Chromogenic Cephalosporin SubstrateAntimicrobial Agents and Chemotherapy, 1972
- In-Vitro Interaction of Shigella flexneri with Leukocytes and HeLa CellsThe Journal of Infectious Diseases, 1970